Research Articles >
College of Health Sciences >
Please use this identifier to cite or link to this item:
|Title: ||What predicts non-retention in microbicide trials?|
|Authors: ||Feldblum, Paul J.|
Opoku, Baafuor K.
|Issue Date: ||2011|
|Publisher: ||Elsevier Inc.|
|Citation: ||Contemporary Clinical Trials xxx (2011) xxx–xxx|
|Abstract: ||Background: Poor retention can reduce study power and thwart randomization, possibly
resulting in biased estimates of effect. Some HIV prevention trials conducted in developing
countries have been challenged by high loss to follow-up. Identifying factors associated with
non-retention could lead to recruitment of women more likely to remain in the trial, potentially
yielding greater efficiency and validity.
Methods: We summarized retention rates and, using Cox regression, evaluated factors
associated with non-retention in four trials of two candidate vaginal microbicides (1% C31G
or SAVVY® and 6% cellulose sulfate or CS) conducted in multiple sub-Saharan African countries.
We defined retention as completion of the trial, including those with an HIV outcome. Nonretention
comprised participants randomized to a study arm who were either lost to follow-up
or discontinued prior to infection with HIV.
Results: 7367 women were enrolled and randomized in the four trials; 7086 are included in this
analysis. 1514 (21.4%) participants were either lost to follow-up or had early discontinuation.
In the final Cox model, the following baseline factors were associated with non-retention:
younger age (hazard ratio [HR]=0.95); less education (HR=0.97); condom use at last sex
(HR=1.18); larger number of sex acts in a typical week (HR=1.01); and baseline candidiasis
or bacterial vaginosis (HR=1.12).
Conclusions: Younger and less educated women were more difficult to retain in these
microbicide trials. But these same traits may be associated with higher HIV infection rates.
Enhanced retention methods focused on those at highest risk of non-retention and possibly
infection will optimize study efficiency and validity.|
|Description: ||Article published by Elsevier Inc.|
|Appears in Collections:||College of Health Sciences|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.